These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [5-fluorouracil in high doses. Principles and toxicity]. Fleischer I; Wainstein R; Milano MC Acta Gastroenterol Latinoam; 1985; 15(3):165-70. PubMed ID: 3836545 [TBL] [Abstract][Full Text] [Related]
7. Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro. Schwartz PM; Handschumacher RE Cancer Res; 1979 Aug; 39(8):3095-101. PubMed ID: 455294 [No Abstract] [Full Text] [Related]
8. Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes. Tsavaris N; Caragiauris P; Kosmidis P Eur J Surg Oncol; 1988 Oct; 14(5):405-6. PubMed ID: 3181443 [TBL] [Abstract][Full Text] [Related]
9. [Protective effect of allopurinol during chemotherapy with 5-fluorouracil of mouse blast leukemia]. Bukhman VM; Mamedov FF Biull Eksp Biol Med; 1983 Aug; 96(8):84-6. PubMed ID: 6882910 [TBL] [Abstract][Full Text] [Related]
10. Treatment of 5-fluorouracil-induced stomatitis by allopurinol mouthwashes. Elzawawy A Oncology; 1991; 48(4):282-4. PubMed ID: 1891169 [TBL] [Abstract][Full Text] [Related]
11. Prediction of marrow toxicity in patients treated by intravenous infusion of 5 fluorouracil. Hillcoat BL; Banerjee M; McCulloch PB; Williams CK Eur J Cancer (1965); 1977 Jan; 13(1):81-7. PubMed ID: 844477 [No Abstract] [Full Text] [Related]
12. Phase II trial of high-dose continuous infusion 5-fluorouracil with allopurinol modulation in colon cancer. Ahmann FR; Garewal H; Greenberg BR Oncology; 1986; 43(2):83-5. PubMed ID: 3951789 [TBL] [Abstract][Full Text] [Related]
13. 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer. Kroener JF; Saleh F; Howell SB Cancer Treat Rep; 1982 May; 66(5):1133-7. PubMed ID: 7083215 [TBL] [Abstract][Full Text] [Related]
14. Allopurinol modulation of fluorouracil toxicity. Fox RM; Woods RL; Tattersall MH; Piper AA; Sampson D Cancer Chemother Pharmacol; 1981; 5(3):151-5. PubMed ID: 6457698 [TBL] [Abstract][Full Text] [Related]
15. Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. Clark PI; Slevin ML Eur J Surg Oncol; 1985 Sep; 11(3):267-8. PubMed ID: 4029407 [TBL] [Abstract][Full Text] [Related]
16. Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts. Houghton JA; Houghton PJ Cancer Treat Rep; 1982 May; 66(5):1201-6. PubMed ID: 7083222 [TBL] [Abstract][Full Text] [Related]
17. Protracted ambulatory venous infusion of 5-fluorouracil. Lokich J; Fine N; Perri J; Bothe A Am J Clin Oncol; 1983 Feb; 6(1):103-7. PubMed ID: 6837501 [TBL] [Abstract][Full Text] [Related]
18. A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracil. Woolley PV; Ayoob MJ; Smith FP; Lokey JL; DeGreen P; Marantz A; Schein PS J Clin Oncol; 1985 Jan; 3(1):103-9. PubMed ID: 3965628 [TBL] [Abstract][Full Text] [Related]
19. [5-fluorouracil effectiveness and toxicity in the treatment of digestive trac.t neoplasms as a function of the mode of administration]. Zelechowska JA; Madej G Nowotwory; 1976; 26(1):29-36. PubMed ID: 1257062 [No Abstract] [Full Text] [Related]
20. Allopurinol and bolus fluorouracil. Garewal H; Ahmann F N Engl J Med; 1985 Feb; 312(9):587. PubMed ID: 3969129 [No Abstract] [Full Text] [Related] [Next] [New Search]